TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›ZION
ZION logo

ZION

ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/

Next earnings Jul 20, 2026 · consensus $1.78 EPS, $888M rev

Last earnings +0.5% on 2026-04-20

Buy
$69.35
▼ -0.24%
$69.35▲ +39.09%
over 1Y
L $45.85H $69.52
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-0.2%
1W+0.0%
1M+11.8%
3M+20.2%
YTD+18.8%
1Y+39.1%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Buy
Quality
B
Valuation
Undervalued
Filings
Watch
Buy
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 28 analysts
Buy

Zions is firing on all cylinders — NIM up to 3.21%, EPS +21%, stable credit — yet trades at just 11x earnings and a small premium to book.

Diluted EPS $6.01 · FY2025

The read

Quality fundamentals and an attractive price line up (~99% below fair value) — the rarer case where both the business and the entry look good.

Zions Bancorporation, an $89.0B-asset regional bank operating through seven affiliate banks, delivered a clean, improving FY2025. Diluted EPS rose 21.4% to $6.01 and net income grew 14.7% to $899M, driven by the two levers that matter most for a bank: net interest income increased 8% ($197M) as net interest margin expanded to 3.21% from 3.00% on lower funding costs and a better earning-asset mix, while the efficiency ratio improved to 62.6% from 64.2% — positive operating leverage as revenue outpaced expense growth. Customer noninterest income also rose, helped by capital-markets swap fees and investment-banking advisory income.

Credit quality looks contained: the provision for credit losses was flat at $72M year over year, and the 10-K describes a disciplined, independent three-lines-of-defense credit framework with concentration limits by industry, collateral and geography. Capital strengthened materially — stockholders' equity grew 17.2% to $7.18B (partly reflecting recovering AOCI/securities marks), supporting the dividend and a modest buyback. The 11.39x liabilities/equity is ordinary balance-sheet leverage for a bank, not a red flag.

Is ZION a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Bull call spread (wide)~60d expiry
  • Long call 69 @ ~2.75 est
  • Short call 80 @ ~0.14 est
debit $261max +$839max −$261BE 71.61

High-conviction BUY: a wider spread keeps more of the upside while the short call still cuts cost and decay.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$449M$495M$503M$513M$529M
Gross profit—————
Operating income—————
Net income$1.13B$907M$680M$784M$899M
Diluted EPS$6.79$5.79$4.35$4.95$6.01
Net margin251.4%183.2%135.2%152.8%169.9%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF10.7
PEG (trailing)0.79
Earnings yield8.8%
FCF yield9.3%

Quality & risk

ROIC (est.)—
Free cash flow$952M
Total debt$4.05B
Net cash-$3.37B
Piotroski F-Score6/7

Capital returns

Buyback yield0.4%
Dividend yield (est.)2.6%
Shareholder yield3.0%
Shares Δ YoY-0.0%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Officer / director change2026-06-02
  2. 10-Q Quarterly report2026-05-07
  3. 8-K Other event2026-05-04
  4. 8-K Shareholder vote2026-05-04
  5. 8-K Earnings results2026-04-20
  6. DEF 14A Proxy statement2026-03-19
  7. 10-K Annual report2026-02-24
  8. 8-K Earnings results2026-01-20
  9. 8-K Officer / director change2025-12-22

Recent filings

all on EDGAR ↗
4Period ending 2026-06-302026-07-01open ↗4Period ending 2026-06-302026-07-01open ↗4Period ending 2026-06-302026-07-01open ↗4Period ending 2026-06-302026-07-01open ↗11-KPeriod ending 2026-06-252026-06-25open ↗4Period ending 2026-06-022026-06-04open ↗3Period ending 2026-06-022026-06-04open ↗4Period ending 2026-06-022026-06-03open ↗8-KPeriod ending 2026-06-022026-06-02open ↗4Period ending 2026-05-082026-05-11open ↗13F-HRPeriod ending 2026-03-312026-05-08open ↗4Period ending 2026-05-062026-05-07open ↗

Quality score

B
ValueGrowthProfitHealthMom.
ValueC-
GrowthB
ProfitabilityA
Financial healthA-
MomentumA
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✓Net margin above 10%
  • ✗Return on equity above 15%
  • ✓P/E below 25

Fair value est.

$137.82

Undervalued +99% vs price

cheapfair valueexpensive

Modified Graham: EPS $6.01 × (8.5 + 1.5 × 8.9% growth) × 1.05 quality = 22.9× multiple. An estimate, not a price target.

45.8552-week70.70
Revenue
$529M
+3.1% YoY
Net margin
169.9%
ROE
12.5%
P/E
11.5

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$529M+3.1%
Net income$899M+14.7%
Diluted EPS$6.01+21.4%
Cash & equivalents$683M+4.9%
Total assets$89.0B+0.2%
Total liabilities$81.8B-1.0%
Stockholders' equity$7.18B+17.2%
L/E: 11.39x

Frequently asked

Is ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ (ZION) a buy?
ZION currently carries a Buy rating with 4/5 conviction, derived from its latest SEC filings. Zions is firing on all cylinders — NIM up to 3.21%, EPS +21%, stable credit — yet trades at just 11x earnings and a small premium to book.
What is ZION's fair value?
A Modified-Graham model based on ZION's SEC fundamentals estimates a fair value of about $137.82. It is an estimate from reported earnings, not a price target.
Is ZION overvalued or undervalued?
Against a Modified-Graham fair-value estimate, ZION currently appears undervalued relative to its SEC-grounded earnings power.
What is ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/'s quality score?
ZION scores 74.96798917646836/100 (grade B) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000109380, latest 10-Q filed 2026-05-07) · EODHD · Proprietary analysis · as of 6/21/2026, 8:52:06 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:52 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 0 open-market buys · 1 sale

2026-06-02
Callister Nathan
Executive Vice President
Tax922.00 @ $62.02$57.2K
2026-05-08
Smith Jennifer Anne
Executive Vice President
Sell4.21K @ $62.50$263K
2026-05-06
Richards Robert Ryan
Controller
Exercise2.00K @ $52.90$106K

Earnings history

beat/miss · move
2026-04-20Beat +7.3% est▲ +2.47%8-K ↗
2026-01-20Beat +10.4% est▲ +3.81%8-K ↗
2025-10-20Beat +2.8% est▲ +6.95%8-K ↗
2025-07-21Beat +21.8% est▼ -2.18%8-K ↗
2025-04-21—▲ +3.86%8-K ↗
2025-01-21—▼ -0.31%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

Disclosed under the STOCK Act

2025-05-06Gilbert CisnerosSell$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Vs tracked universe

compare →

1194 tracked peers · median

TENK Score75 vs 67
Revenue growth3.1% vs 7.5%
Net margin169.9% vs 10.0%
Return on equity12.5% vs 12.0%
P/E11.5 vs 26.2